NDUFB10

Across TCGA pan-cancer cohorts, NDUFB10 mass-spec protein is linked to patient survival in 7 of 34 cancer types, making it a survival-associated NDUFB10 data layer compared with 23 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher NDUFB10 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated NDUFB10 expression acts as an unfavorable survival marker, although some lineages such as LUAD and CCRCC show a favorable association.

LUAD, CCRCC, and GBM are the cancer types where NDUFB10 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	III,IV	0.678	0.279	.033	6	view →
CCRCC	OS	Quartile	All	0.950	0.734	.022	4	view →
GBM	DFS	Median	All	0.214	0.412	.029	3	view →
LSCC	DFS	Tertile	All	0.422	0.986	.031	3	view →
UCEC	OS	Quartile	All	1.000	0.849	.040	2	view →
HNSC	DFS	Quartile	II,III,IV	0.852	0.980	.024	2	view →
PDAC	DFS	Median	III,IV	0.547	0.213	.027	2	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

NDUFB10–LUAD (OS)

Open the LUAD breakdown →